Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Signed multi-year Technology Investment Agreement with Defense Advanced Research Projects Agency (DARPA) with contract value of approximately $35 million Q3 2015 revenues of $8.6 million were...
-
EMERYVILLE, Calif., Oct. 30, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, is pleased to announce it has been recognized by the East Bay Chapter of the United...
-
EMERYVILLE, Calif., Oct. 21, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the third quarter ended September 30, 2015 after market close on Thursday, November...
-
EMERYVILLE, Calif., Oct. 21, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that Denver-based Adam's Polishes (www.adamspolishes.com) has...
-
EMERYVILLE, Calif., Oct. 20, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, is pleased to announce it has won a SEPAWA Innovation Award 2015 for its...
-
EMERYVILLE, Calif., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has priced its previously announced private offering of...
-
EMERYVILLE, Calif., Oct. 14, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced the offering, subject to market conditions, of $50 million of...
-
EMERYVILLE, Calif., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that after achieving a record low manufacturing cost of $1.75 per...
-
EMERYVILLE, Calif., Oct. 6, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced the manufacturing of its third product produced this year at its...
-
EMERYVILLE, Calif., Sept. 23, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced a multi-year, Technology Investment Agreement (TIA) worth up to...